Plasmid-Based shRNA – An Effective Antiviral Strategy Against Chikungunya Virus InfectionTuesday, 22 November 2011 at 16:30  Add to Calendar ▼2011-11-22 16:30:002011-11-22 17:30:00Europe/LondonPlasmid-Based shRNA – An Effective Antiviral Strategy Against Chikungunya Virus InfectionRNAi Asia in SingaporeSingaporeSELECTBIOenquiries@selectbiosciences.comThe mosquito-borne Chikungunya virus (CHIKV) is known to cause Chikungunya fever in humans. Our study has demonstrated the high anti-CHIKV efficacy of shRNA (small-hairpin RNA) that were designed against three CHIKV genes against Chikungunya virus infection in human cells. Hence, shRNA technology is proposed as a novel antiviral strategy for this re-emerging viral disease. |
Add to Calendar ▼2011-11-22 00:00:002011-11-23 00:00:00Europe/LondonRNAi AsiaRNAi Asia in SingaporeSingaporeSELECTBIOenquiries@selectbiosciences.com
